Investigational Gene-Based Therapy for Alpha-1 Antitrypsin (AAT) Deficiency Demonstrates Durable Response at Five Years
Research led by scientists from the University of Massachusetts Medical School presented at the American Society of Gene and Cell Therapy (ASGTC) Annual Meeting
WASHINGTON, May 05, 2016 -- (Healthcare Sales & Marketing Network) -- Researchers from the U... BiopharmaceuticalsApplied Genetic Technologies, gene therapy, Alpha-1 Antitrypsin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news